Global Joint Venture Partnerships in Pharma, Biotech and Diagnostics 2010-2015

Jul 13, 2015, 12:51 ET from Research and Markets

DUBLIN, July 08, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/7ckh78/global_joint) has announced the addition of the "Global Joint Venture Partnerships in Pharma, Biotech and Diagnostics 2010-2015" report to their offering.

Global Joint Venture Partnerships in Pharma, Biotech and Diagnostics 2010-2015 report is intended to provide the reader with an in-depth understanding of the joint venture trends and structure of deals entered into by leading biopharma companies worldwide.

Global Joint Venture Partnerships in Pharma, Biotech and Diagnostics 2010-2015 includes:

  • Trends in joint venture dealmaking in the biopharma industry since 2010
  • Analysis of joint venture deal structure
  • Case studies of real-life joint venture deals
  • Access to over 450 joint venture deal records
  • Detailed access to actual joint venture contract documents
  • The leading joint venture deals by value since 2010
  • Most active joint venture dealmakers since 2010
  • The leading joint venture partnering resources

In Global Joint Venture Partnerships in Pharma, Biotech and Diagnostics 2010- 2015, the available contracts are listed by:

  • Company A-Z
  • Headline value
  • Stage of development at signing
  • Therapeutic area
  • Technology area

The Global Joint Venture Partnerships in Pharma, Biotech and Diagnostics 2010- 2015 report provides comprehensive access to records for over 450 joint venture deals.

Analyzing actual contract agreements allows assessment of the following:

  • What are the precise joint venture rights granted or optioned?
  • What is actually granted by the agreement to the partner company?
  • What exclusivity is granted?
  • What is the payment structure for the deal?
  • How aresalesand payments audited?
  • What is the deal term?
  • How are the key terms of the agreement defined?
  • How are IPRs handled and owned?
  • Who is responsible for commercialization?
  • Who is responsible for development, supply, and manufacture?
  • How is confidentiality and publication managed?
  • How are disputes to be resolved?
  • Under what conditions can the deal be terminated?
  • What happens when there is a change of ownership?
  • What sublicensing and subcontracting provisions have been agreed?
  • Which boilerplate clauses does the company insist upon?
  • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
  • Which jurisdiction does the company insist upon for agreement law

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Trends in joint venture partnerships

Chapter 3 Overview of joint venture deal structure

Chapter 4 Leading joint venture deals

Chapter 5 Big pharma joint venture deals

Chapter 6 Big biotech joint venture deals

Chapter 7 Joint venture contract directory 2010-2015

For more information visit http://www.researchandmarkets.com/research/7ckh78/global_joint

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets



RELATED LINKS

http://www.researchandmarkets.com